662 related articles for article (PubMed ID: 28445785)
1. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
Seilie ES; Bubeck Wardenburg J
Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
[TBL] [Abstract][Full Text] [Related]
2. Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.
Flammier S; Rasigade JP; Badiou C; Henry T; Vandenesch F; Laurent F; Trouillet-Assant S
PLoS One; 2016; 11(3):e0150693. PubMed ID: 26934588
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.
Haapasalo K; Wollman AJM; de Haas CJC; van Kessel KPM; van Strijp JAG; Leake MC
FASEB J; 2019 Mar; 33(3):3807-3824. PubMed ID: 30509126
[TBL] [Abstract][Full Text] [Related]
4. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.
Spaan AN; Henry T; van Rooijen WJM; Perret M; Badiou C; Aerts PC; Kemmink J; de Haas CJC; van Kessel KPM; Vandenesch F; Lina G; van Strijp JAG
Cell Host Microbe; 2013 May; 13(5):584-594. PubMed ID: 23684309
[TBL] [Abstract][Full Text] [Related]
5. The bicomponent pore-forming leucocidins of Staphylococcus aureus.
Alonzo F; Torres VJ
Microbiol Mol Biol Rev; 2014 Jun; 78(2):199-230. PubMed ID: 24847020
[TBL] [Abstract][Full Text] [Related]
6. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
[TBL] [Abstract][Full Text] [Related]
7. Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity.
Tromp AT; Van Gent M; Jansen JP; Scheepmaker LM; Velthuizen A; De Haas CJC; Van Kessel KPM; Bardoel BW; Boettcher M; McManus MT; Van Strijp JAG; Lebbink RJ; Haas PA; Spaan AN
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32041354
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.
Balasubramanian D; Ohneck EA; Chapman J; Weiss A; Kim MK; Reyes-Robles T; Zhong J; Shaw LN; Lun DS; Ueberheide B; Shopsin B; Torres VJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27329753
[TBL] [Abstract][Full Text] [Related]
9. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice.
Lubkin A; Lee WL; Alonzo F; Wang C; Aligo J; Keller M; Girgis NM; Reyes-Robles T; Chan R; O'Malley A; Buckley P; Vozhilla N; Vasquez MT; Su J; Sugiyama M; Yeung ST; Coffre M; Bajwa S; Chen E; Martin P; Kim SY; Loomis C; Worthen GS; Shopsin B; Khanna KM; Weinstock D; Lynch AS; Koralov SB; Loke P; Cadwell K; Torres VJ
Cell Host Microbe; 2019 Mar; 25(3):463-470.e9. PubMed ID: 30799265
[TBL] [Abstract][Full Text] [Related]
11. Infection of Primary Human Alveolar Macrophages Alters Staphylococcus aureus Toxin Production and Activity.
Brann KR; Fullerton MS; Onyilagha FI; Prince AA; Kurten RC; Rom JS; Blevins JS; Smeltzer MS; Voth DE
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010814
[TBL] [Abstract][Full Text] [Related]
12. Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.
Yoong P; Torres VJ
Nat Commun; 2015 Sep; 6():8125. PubMed ID: 26330208
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.
Scherr TD; Hanke ML; Huang O; James DB; Horswill AR; Bayles KW; Fey PD; Torres VJ; Kielian T
mBio; 2015 Aug; 6(4):. PubMed ID: 26307164
[TBL] [Abstract][Full Text] [Related]
14. Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus.
Koop G; Vrieling M; Storisteanu DM; Lok LS; Monie T; van Wigcheren G; Raisen C; Ba X; Gleadall N; Hadjirin N; Timmerman AJ; Wagenaar JA; Klunder HM; Fitzgerald JR; Zadoks R; Paterson GK; Torres C; Waller AS; Loeffler A; Loncaric I; Hoet AE; Bergström K; De Martino L; Pomba C; de Lencastre H; Ben Slama K; Gharsa H; Richardson EJ; Chilvers ER; de Haas C; van Kessel K; van Strijp JA; Harrison EM; Holmes MA
Sci Rep; 2017 Jan; 7():40660. PubMed ID: 28106142
[TBL] [Abstract][Full Text] [Related]
15. Bovine Staphylococcus aureus Secretes the Leukocidin LukMF' To Kill Migrating Neutrophils through CCR1.
Vrieling M; Koymans KJ; Heesterbeek DA; Aerts PC; Rutten VP; de Haas CJ; van Kessel KP; Koets AP; Nijland R; van Strijp JA
mBio; 2015 Jun; 6(3):e00335. PubMed ID: 26045537
[TBL] [Abstract][Full Text] [Related]
16. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
Badarau A; Trstenjak N; Nagy E
Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
[TBL] [Abstract][Full Text] [Related]
17. Unlatching of the stem domains in the Staphylococcus aureus pore-forming leukocidin LukAB influences toxin oligomerization.
Ilmain JK; Perelman SS; Panepinto MC; Irnov I; Coudray N; Samhadaneh N; Pironti A; Ueberheide B; Ekiert DC; Bhabha G; Torres VJ
J Biol Chem; 2023 Dec; 299(12):105321. PubMed ID: 37802313
[TBL] [Abstract][Full Text] [Related]
18. Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.
Reyes-Robles T; Lubkin A; Alonzo F; Lacy DB; Torres VJ
EMBO Rep; 2016 Mar; 17(3):428-40. PubMed ID: 26882549
[TBL] [Abstract][Full Text] [Related]
19.
Berends ETM; Zheng X; Zwack EE; Ménager MM; Cammer M; Shopsin B; Torres VJ
mBio; 2019 Jan; 10(1):. PubMed ID: 30602580
[No Abstract] [Full Text] [Related]
20. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1.
DuMont AL; Yoong P; Day CJ; Alonzo F; McDonald WH; Jennings MP; Torres VJ
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10794-9. PubMed ID: 23754403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
